361
362
363
364
365
366
367
368
Versteegh, Matthijs M., Vermeulen, Karin M., Evers, Silvia M. A. A., de Wit, G. Ardine, Prenger, Rilana, Stolk, Elly A.
Veröffentlicht in: Versteegh , M M , Vermeulen , K M , Evers , S M A A , de Wit , G A , Prenger , R & Stolk , E A 2016 , ' Dutch Tariff for the Five-Level Version of EQ-5D ' , Value in Health , vol. 19 , no. 4 , pp. 343-352 . https://doi.org/10.1016/j.jval.2016.01.003;
2016
Veröffentlicht in: Versteegh , M M , Vermeulen , K M , Evers , S M A A , de Wit , G A , Prenger , R & Stolk , E A 2016 , ' Dutch Tariff for the Five-Level Version of EQ-5D ' , Value in Health , vol. 19 , no. 4 , pp. 343-352 . https://doi.org/10.1016/j.jval.2016.01.003;
2016
369
Janssen, Paul G. H., Gorter, Kees J., Stolk, Ronald P., Rutten, Guy E. H. M.
Veröffentlicht in: Janssen , P G H , Gorter , K J , Stolk , R P & Rutten , G E H M 2009 , ' Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes : 1-year data from the ADDITION Netherlands study ' , British Journal of General Practice , vol. 59 , no. 558 , pp. 43-48 . https://doi.org/10.3399/bjgp09X394851;
2009
Veröffentlicht in: Janssen , P G H , Gorter , K J , Stolk , R P & Rutten , G E H M 2009 , ' Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes : 1-year data from the ADDITION Netherlands study ' , British Journal of General Practice , vol. 59 , no. 558 , pp. 43-48 . https://doi.org/10.3399/bjgp09X394851;
2009
370